Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D. Hellmann, Maximilian Diehn, Hira Rizvi et al.|Clinical Cancer Research|2020Cited by 123